BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36972047)

  • 1. Patient Cost-Sharing and Utilization of Breast Cancer Diagnostic Imaging by Patients Undergoing Subsequent Testing After a Screening Mammogram.
    Hughes DR; Espinoza W; Fein S; Rula EY; McGinty G
    JAMA Netw Open; 2023 Mar; 6(3):e234893. PubMed ID: 36972047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-Pocket Costs Among Patients With a New Cancer Diagnosis Enrolled in High-Deductible Health Plans vs Traditional Insurance.
    Fu SJ; Rose L; Dawes AJ; Knowlton LM; Ruddy KJ; Morris AM
    JAMA Netw Open; 2021 Dec; 4(12):e2134282. PubMed ID: 34935922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women.
    Ganguli I; Keating NL; Thakore N; Lii J; Raza S; Pace LE
    JAMA Netw Open; 2022 Apr; 5(4):e227234. PubMed ID: 35416989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial Burden of Traumatic Injury Amongst the Privately Insured.
    Fu SJ; Arnow K; Trickey A; Spain DA; Morris A; Knowlton L
    Ann Surg; 2022 Mar; 275(3):424-432. PubMed ID: 34596072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening.
    Pan IW; Oeffinger KC; Shih YT
    J Natl Cancer Inst; 2022 Feb; 114(2):254-262. PubMed ID: 34320199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
    Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
    Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
    Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
    McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
    J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of Out-of-Pocket Costs on Subsequent Mammography Screening.
    Tran L; Chetlen AL; Leslie DL; Segel JE
    J Am Coll Radiol; 2022 Jan; 19(1 Pt A):24-34. PubMed ID: 34748732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment.
    Wharam JF; Wallace J; Argetsinger S; Zhang F; Lu CY; Stryjewski TP; Ross-Degnan D; Newhouse JP
    Diabetes Care; 2022 Aug; 45(8):1754-1761. PubMed ID: 34588211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act.
    Carlos RC; Fendrick AM; Kolenic G; Kamdar N; Kobernik E; Bell S; Dalton VK
    J Am Coll Radiol; 2019 Jun; 16(6):788-796. PubMed ID: 30833168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-Pocket Spending for Non-Birth-Related Hospitalizations of Privately Insured US Children, 2017 to 2019.
    Carlton EF; Becker NV; Moniz MH; Scott JW; Prescott HC; Chua KP
    JAMA Pediatr; 2023 May; 177(5):516-525. PubMed ID: 36972040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties.
    Virk-Baker MK; Martin MY; Levine RS; Wang X; Nagy TR; Pisu M
    Cancer Causes Control; 2013 Dec; 24(12):2187-96. PubMed ID: 24077760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women.
    Sabatino SA; Thompson TD; Miller JW; Breen N; White MC; Breslau E; Shoemaker ML
    J Womens Health (Larchmt); 2019 Jul; 28(7):910-918. PubMed ID: 30265611
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
    Jazowski SA; Wilson L; Dusetzina SB; Zafar SY; Zullig LL
    JAMA Netw Open; 2022 Jun; 5(6):e2215720. PubMed ID: 35671056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography.
    Tye S; Phillips KA; Liang SY; Haas JS
    Health Serv Res; 2004 Feb; 39(1):179-206. PubMed ID: 14965083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.
    Wharam JF; Zhang F; Lu CY; Wagner AK; Nekhlyudov L; Earle CC; Soumerai SB; Ross-Degnan D
    J Clin Oncol; 2018 Apr; 36(11):1121-1127. PubMed ID: 29489428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Commercial Health Insurance Characteristics in Bariatric Surgery Utilization.
    Chhabra KR; Fan Z; Chao GF; Dimick JB; Telem DA
    Ann Surg; 2021 Jun; 273(6):1150-1156. PubMed ID: 31714318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.